Tracer library / [18F]AlF-OncoFAP-NODAGA

[18F]AlF-OncoFAP-NODAGA

Also written as [18F]AlF-OncoFAP-NODAGA; [F-18]AlF-OncoFAP-NODAGA
Radionuclide
F-18 t½ 109.7 min
Modality
PET
Production route
Cyclotron liquid target
Stage
Research
Syntheses indexed
0

What it is

Compound class
Small molecule chelate
Target / mechanism
FAP PMID 34957527 / DOI 10.1007/s00259-021-05653-0
Clinical application
—
Theranostic pair
[177Lu]Lu-OncoFAP-DOTAGA

Regulatory status

FDA
No Drugs@FDA / openFDA drug registry — no approved application found; search: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process&searchTerm=OncoFAP
EMA (centralised)
—
Other approvals
—
Brand names
—

Published syntheses

No synthesis has been parsed for this agent yet.

Precursor

Common precursor
NODAGA-OncoFAP conjugate (from OncoFAP-COOH) PMID 36015106 / DOI 10.3390/ph15080958
Suppliers seen in the literature
—
Typical final purification
HPLC

Need this precursor?We can point you to suppliers for [18F]AlF-OncoFAP-NODAGA, or handle the enquiry for you.

Get in touch

Quality control Preliminary - inferred from compound class

Ph. Eur. monograph
not verified No Ph. Eur. check is recorded for this entry.
USP monograph
not verified No USP check is recorded for this entry.
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrityMolar activity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); receptor ligand with a saturable target -> molar activity (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]AlF-OncoFAP-NODAGA.

Get in touch

Notes

Aluminium fluoride chelation route.
Ask a question